Drug duo tested to shield cancer patients from agonizing radiation sores
NCT ID NCT06031012
Summary
This study tested whether adding the drug thalidomide to a nutritional supplement (glutamine) is better than glutamine alone at preventing or delaying severe mouth sores in patients receiving radiation therapy for head and neck cancers. 138 adult patients were randomly assigned to receive one of the two treatment plans. The main goal was to see if the combination could help patients go longer without developing these painful sores.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCOSITIS ORAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University
Xi'an, Shaanxi, 710032, China
Conditions
Explore the condition pages connected to this study.